Scientific Day 2026

This year, Epicentre’s Scientific Day will take place on June 4, 2026, at the Palais de la Femme, 94 rue de Charonne, 75011 Paris. The event will also be streamed live on our website.

This edition holds particular significance, as it marks Epicentre’s 40th anniversary: four decades of epidemiological expertise and steadfast commitment to supporting humanitarian action.

• Maryline Bonnet, President of Epicentre

Moderators: Emmanuel Baron, former Director of Epicentre, and TBC

• Finding tuberculosis in children with severe acute malnutrition: a multi-country observational study | Muhammad Bashir Abdullahi, Medical doctor, MSF Nigeria
• Evaluation of AI-based computer-aided detection for chest X-ray interpretation for TB diagnosis in children | Juno Min, Diagnostic Imaging Advisor at MSF
• Shortening the path to cure: Insights from implementing a 4‑Month TB regimen for children in Uganda and the Philippines | Danica Galvan, Medical research manager, MSF Philippines & Cecilia Akatukwasa, Qualitative researcher, Epicentre Uganda

Moderators:  Rebecca Grais, Director of the Pasteur Network and former Director of Research at Epicentre & moderator to be confirmed

• Incidence of Lassa fever disease in hotspot communities of West Africa: insights from the Enable programme | Laura Cooper, Epidémiologiste,  Epicentre
• Heterogeneity and Determinants of Ebola Transmission: insights from the 10th DRC outbreak | Hugo Soubrier, Epidémiologiste, Epicentre

Moderators: to be confirmed

• Real-World evidence on uptake and persistent use of long-acting injectable Cabotegravir (CAB-LA) offered as HIV prevention alternative in female sex work hotspots, Malawi | Caoimhe O’Regan, Epidemiologist, Epicentre Malawi
• The HPV-Automated Visual Evaluation (PAVE) results; Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation (provisional title) | Silvia De Sanjosé, PI of the NCI AVE Network project
• Feasibility and acceptability of hydroxyurea-based treatment for children with Sickle Cell Disease in remote rural areas of Niger, 2024–2026 | Delphine Sauvageot, Epidemiologist & Fara Temessadouno, Epidemiologist, Epicentre Dakar
• Healthcare-associated infections: a new tool for surveillance and alerts under development  | Jasper Kim Wagan, Infection Prevention and Control Advisor, MSF

Moderators: Dominique Legros, former Director of Epicentre & moderator to be confirmed

• Cholera dynamics and impact of preventive vaccine in endemic zones of DRC, 2021-2026 | Eve Rahbe, Epidemiologist, Epicentre
• Immune Response to a Delayed Second Dose of Oral Cholera Vaccine: A randomized, controlled, non-inferiority and immunogenicity trial in Conakry, Guinea | Fabienne Nackers, Epidemiologist, Epicentre

Moderators: to be confirmed

• Developing locally-adapted measles vaccination strategies in the Democratic Republic of the Congo | Camille Fortas, Epidemiologist, Epicentre & Neema Musyenene, Epidemiologist, Epicentre RDC
• Evaluation of the Efficacy of the Nm5CV Vaccine in Niger | Medard Djedanem, Epidemiologist, Epicentre Niger

Discussion with 

• Alain Moren, Medical epidemiologist and former director of Epicentre,
• Javid Abdelmoneim, Emergency physician and international president of MSF
• Etienne Gignoux, Epidemiologist and Director of the Department of Interventional Epidemiology and Training at Epicentre

The session will also include presentations of recent surveys and studies conducted in Gaza and Sudan.

• Javid Abdelmoneim, Emergency doctor and international president of MSF
• Klaudia Porten, Executive Director of Epicentre

You can register now.